<!DOCTYPE html>
<html>

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width">
  <title>ACE Inhibitors</title>
  <link href="style.css" rel="stylesheet" type="text/css" />
</head>

<body>
  <h1>ACE Inhibitors</h1>
  <h2>(Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Trandolapril)</h2>
  <p><span class="pregnancy-recommendation">Pregnancy Recommendation:</span> Human data suggest risk in all trimesters.</p>
  <p><span class="breastfeeding-recommendation">Breast-feeding Reecommendation:</span> No-human data - Probably compatible</p>
  <p><span class="pregnancy-summary">Pregnancy Summary:</span> The fetal toxicity of ACE inhibitors in the 2nd and 3rd trimesters is similar to other angiotensin-converting enzyme (ACE) inhibitors. The use of this drug during the 2nd and 3rd trimesters may cause teratogenicity and severe fetal and neonatal toxicity.</p>
  <p><span class="breastfeeding-summary">Breast-feeding Summary:</span> No reports describing the use of ACE inhibitors during human lactation have been located. The most common adverse reactions observed in adults were headache, dizziness, cough, hypotension, and chest pain</p>
</body>

<h3>Reference</h3>
<p>Briggs, G. G., Towers, C. V., & Freeman, R. K. (2021). Briggs drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk (12th ed.). Lippincott Williams & Wilkins (LWW). </p>
  
</html>
